Who backs ViTToria Biotherapeutics?
15 investors| Investor | Type |
|---|---|
| KB Investment | Venture capital |
| Ben Franklin Technology Partners of Southeastern Pennsylvania | Other |
| SV Health Investors | Venture capital |
| BioAdvance Capital (Conshohocken) | Venture capital |
| NYBC Ventures | Venture capital |
| Agent Capital | — |
| Global BioAccess Fund | — |
| Hatch Biofund Management | — |
| Knollwood Investment Fund | — |
| Leukemia & Lymphoma Society | — |
| + 5 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
ViTToria Biotherapeutics investors
15 investors are on record for ViTToria Biotherapeutics, including KB Investment, Ben Franklin Technology Partners of Southeastern Pennsylvania, SV Health Investors and BioAdvance Capital (Conshohocken). The early-stage round in Jul 2021 drew 11 investors.
Free account
More of ViTToria Biotherapeutics with a free account
- ·The complete investor list: 15 names
- ·Watch ViTToria Biotherapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 15 firms already write checks for companies like ViTToria Biotherapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View